ACURA PHARMACEUTICALS, INC: debt financing — Acura gets $200K loan from controlling shareholder; warns bankruptcy possible if no new funds by early June

ACURA PHARMACEUTICALS, INC

AD Pharma loaned $200K on May 10; total principal now $5.62M at 5.25%, due June 30, 2024.
Accrued interest ~$310K; default rate rises to 7.5% after 5-day grace.
Without additional financing by early June 2024, Acura may scale back operations or seek bankruptcy protection.
AD Pharma directly owns ~65% of Acura common stock; Mr. Schutte (AD Pharma manager) owns ~13% directly.
Loan proceeds used for day-to-day operations; no assurance further funding will be available.

item 1.01 item 2.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

ACURA PHARMACEUTICALS, INC incurred loan of $200,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing June 30, 2024.

Instrument: loan
Principal: $200,000
Counterparty: Abuse Deterrent Pharma, LLC
Rate: 5.25%
Maturity: June 30, 2024
Event: incurrence

Exact text from the filing

On May 10, 2024 we received a $200,000 loan from Abuse Deterrent Pharma, LLC (“AD Pharma”). This loan combined with previous loans made to the Company and combined with the $2,319,279 under the November 10, 2022 Amended Consolidated and Restated Secured Promissory Note, now has a principal balance of $5,619,279 with accrued interest of approximately $310,000, bears interest at 5.25%, and matures on June 30, 2024, at which time all principal and interest is due (“Note”).

View on SEC.gov

310 debt financings filed in the last 30 days. Browse all debt financings →

Source: SEC EDGAR

accession 0001104659-24-061200

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.